Holen Sie sich die Stockscreener-App
13.18
3.45%
0.42
Schlusskurs vom Vortag:
$12.76
Offen:
$12.88
24-Stunden-Volumen:
128.04K
Relative Volume:
0.63
Marktkapitalisierung:
$528.84M
Einnahmen:
$52.65M
Nettoeinkommen (Verlust:
$7.70M
KGV:
63.79
EPS:
0.2066
Netto-Cashflow:
$15.22M
1W Leistung:
-2.22%
1M Leistung:
+14.09%
6M Leistung:
+75.18%
1J Leistung:
+178.78%
1-Tages-Spanne:
$12.76
$13.43
1-Wochen-Bereich:
$12.41
$14.05
52-Wochen-Spanne:
$3.92
$14.65
Brainsway Ltd Adr Stock (BWAY) Company Profile
Firmenname
Brainsway Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare BWAY vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
13.21 | 510.82M | 52.65M | 7.70M | 15.22M | 0.2066 |
ABT
Abbott Laboratories
|
102.27 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
326.56 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.20 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.90 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-03-03 | Eingeleitet | Loop Capital | Buy |
| 2021-07-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-20 | Eingeleitet | Northland Capital | Outperform |
| 2019-05-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-05-13 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-13 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Brainsway Ltd Adr Aktie (BWAY) Neueste Nachrichten
Here's why momentum in Brainsway (BWAY) should keep going - MSN
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm
Form 6K Brainsway Ltd. For: 19 March - Investing.com
Equities Analysts Issue Forecasts for Brainsway Q1 Earnings - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 12-Month High on Better-Than-Expected Earnings - defenseworld.net
Micron To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday - Sahm
Northland Securities Estimates Brainsway Q1 Earnings - Defense World
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Growth in Short Interest - MarketBeat
Brainsway Q1 EPS Estimate Reduced by Northland Securities - MarketBeat
Brainsway (NASDAQ:BWAY) Hits New 1-Year High on Earnings Beat - MarketBeat
Brainsway Q4 Earnings Call Highlights - Yahoo Finance
Northland Securities Comments on Brainsway FY2025 Earnings - MarketBeat
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Sahm
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Declines By 41.9% - MarketBeat
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026 - ChartMill
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day - ChartMill
Molson Coors Beverage, Carvana, Avis Budget And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
BrainsWay invests $1 million in Canadian mental health provider BrainStim By Investing.com - Investing.com
Brainsway Stock Set to Split on Tuesday, March 3rd (NASDAQ:BWAY) - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 12-Month HighWhat's Next? - MarketBeat
BrainsWay doubles U.S. ADS count in 2-for-1 split on Mar. 3 - Stock Titan
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Significant Decrease in Short Interest - MarketBeat
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Rises By 116.5% - MarketBeat
Phoenix Financial Ltd. Has $949,000 Stake in Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 52-Week HighTime to Buy? - MarketBeat
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Northland Securities Predicts Brainsway Q3 Earnings - MarketBeat
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™ - ChartMill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Down 21.1% in December - MarketBeat
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - sharewise.com
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) - Chartmill
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™ - Chartmill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Update - MarketBeat
Investment Analysts’ Weekly Ratings Updates for Brainsway (BWAY) - Defense World
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens - Eastern Progress
Are Options Traders Betting on a Big Move in BrainsWay Stock? - sharewise.com
BrainsWay Ltd. (NASDAQ:BWAY) Expanding Reach In Mental Health Care - Kalkine Media
FY2025 EPS Estimate for Brainsway Decreased by Analyst - Defense World
Northland Capmk Reduces Earnings Estimates for Brainsway - MarketBeat
Northland Capmk Predicts Weaker Earnings for Brainsway - Defense World
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewswire Inc.
Brainsway (NASDAQ:BWAY) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Brainsway (BWAY) Projected to Post Earnings on Tuesday - Defense World
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? - sharewise.com
HC Wainwright Has Bearish Forecast for Brainsway Q4 Earnings - MarketBeat
Finanzdaten der Brainsway Ltd Adr-Aktie (BWAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):